DK2618842T3 - Hidtil ukendt immunstimulerende fremgangsmåde - Google Patents
Hidtil ukendt immunstimulerende fremgangsmåde Download PDFInfo
- Publication number
- DK2618842T3 DK2618842T3 DK11826223.7T DK11826223T DK2618842T3 DK 2618842 T3 DK2618842 T3 DK 2618842T3 DK 11826223 T DK11826223 T DK 11826223T DK 2618842 T3 DK2618842 T3 DK 2618842T3
- Authority
- DK
- Denmark
- Prior art keywords
- immunicative
- unknown
- procedure
- unknown immunicative
- immunicative procedure
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2010904284A AU2010904284A0 (en) | 2010-09-22 | Novel Immunostimulatory Method | |
| AU2011902408A AU2011902408A0 (en) | 2011-06-20 | Novel immunstimulatory method | |
| PCT/AU2011/001225 WO2012037612A1 (en) | 2010-09-22 | 2011-09-22 | Novel immunostimulatory method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2618842T3 true DK2618842T3 (da) | 2019-07-01 |
Family
ID=45873313
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK11826223.7T DK2618842T3 (da) | 2010-09-22 | 2011-09-22 | Hidtil ukendt immunstimulerende fremgangsmåde |
Country Status (10)
| Country | Link |
|---|---|
| US (5) | US9676819B2 (da) |
| EP (3) | EP2618842B1 (da) |
| JP (5) | JP2013537892A (da) |
| CN (2) | CN105477640B (da) |
| AU (1) | AU2011305061B2 (da) |
| CA (1) | CA2811957C (da) |
| DK (1) | DK2618842T3 (da) |
| ES (1) | ES2735274T3 (da) |
| PL (1) | PL2618842T3 (da) |
| WO (1) | WO2012037612A1 (da) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012037612A1 (en) * | 2010-09-22 | 2012-03-29 | The University Of Melbourne | Novel immunostimulatory method |
| CN105555756B (zh) | 2013-06-28 | 2018-12-07 | 奥克兰联合服务有限公司 | 氨基酸缀合物和肽缀合物及缀合方法 |
| WO2016037240A1 (en) * | 2014-09-12 | 2016-03-17 | The University Of Melbourne | Immunological reagent |
| KR20170094449A (ko) | 2014-12-23 | 2017-08-17 | 마가렛 앤 브림블 | 아미노산 및 펩타이드 접합체 및 이들의 용도 |
| CA3014515A1 (en) | 2016-02-26 | 2017-08-31 | Auckland Uniservices Limited | Amino acid and peptide conjugates and conjugation process |
| JP2020512336A (ja) * | 2017-03-31 | 2020-04-23 | イーナ セラピューティクス ピーティーワイ リミテッド | Ｔｌｒアゴニストによる呼吸器感染症の治療 |
| WO2019119069A1 (en) * | 2017-12-21 | 2019-06-27 | Ena Therapeutics Pty Ltd | Administration of a tlr2 agonist for the treatment or prevention of a respiratory condition associated with an infectious agent |
| EP4025203A4 (en) * | 2019-09-04 | 2023-12-20 | Axelia Oncology Pty Ltd | CANCER TREATMENT |
| AU2020340468A1 (en) * | 2019-09-04 | 2022-03-24 | Axelia Oncology Pty Ltd | Cancer immunotherapy |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4119856A1 (de) | 1991-06-17 | 1992-12-24 | Hoechst Ag | N-acyl-s-(2-hydroxyalkyl)-cysteine, deren herstellung sowie deren verwendung als zwischenprodukte zur herstellung von synthetischen immunadjuvantien und synthetischen impfstoffen |
| NZ518999A (en) | 1999-11-19 | 2002-12-20 | Csl Ltd | Vaccine compositions |
| ES2305086T3 (es) * | 2000-05-19 | 2008-11-01 | Corixa Corporation | Tratamiento profilactico y terapeutico de enfermedades alergicas, autoinmunes e infecciosas con compuestos con base de monosacaridos. |
| EP1382352A1 (de) * | 2002-07-19 | 2004-01-21 | GBF Gesellschaft für Biotechnologische Forschung mbH | Bisacyloxypropylcystein-Konjugate und deren Verwendung |
| CN1688605B (zh) * | 2002-08-12 | 2011-01-12 | 昆士兰医学研究所理事会 | 包含辅助t细胞和细胞毒性t淋巴细胞(ctl)表位的新免疫原性脂肽 |
| US7569225B2 (en) * | 2002-08-12 | 2009-08-04 | The Council Of The Queensland Institute Of Medical Research | Immunogenic lipopeptides comprising T-helper and B-cell epitopes |
| EP1550458A1 (en) | 2003-12-23 | 2005-07-06 | Vectron Therapeutics AG | Synergistic liposomal adjuvants |
| CN1921877A (zh) * | 2004-01-16 | 2007-02-28 | 悉生物有限公司 | 陪伴蛋白10对Toll样受体诱导的细胞因子和趋化因子分泌的调节 |
| WO2005079419A2 (en) | 2004-02-17 | 2005-09-01 | The Regents Of The University Of California | Methods of treating immunopathological disorders |
| GB0405634D0 (en) | 2004-03-12 | 2004-04-21 | Univ Southampton | Anti-virus therapy for respiratory diseases |
| GB0411411D0 (en) | 2004-05-21 | 2004-06-23 | Glaxosmithkline Biolog Sa | Vaccines |
| AU2005295317B2 (en) | 2004-10-18 | 2011-10-13 | Globeimmune, Inc. | Yeast-based therapeutic for chronic hepatitis C infection |
| EP1666056A1 (en) | 2004-12-06 | 2006-06-07 | Bestewil Holding B.V. | Cancer vaccine vesicles |
| SG160424A1 (en) | 2004-12-21 | 2010-04-29 | Vaxinnate Corp | Compositions of influenza viral proteins and methods of use thereof |
| EP1861426A4 (en) | 2005-02-08 | 2008-11-12 | Queensland Inst Med Res | IMMUNOGENOUS MOLECULES |
| WO2006091591A1 (en) * | 2005-02-22 | 2006-08-31 | The Regents Of The University Of California | Methods of treating gastrointestinal inflammation |
| US20080170996A1 (en) | 2006-07-28 | 2008-07-17 | The Board Of Regents Of The University Of Texas System | Compositions and Methods for Stimulation of Lung Innate Immunity |
| CA2702154C (en) * | 2007-10-09 | 2017-05-16 | The University Of Melbourne | A method of transfection and compositions therefor |
| WO2009137103A2 (en) | 2008-05-09 | 2009-11-12 | Ourth Donald D | Anti-cancer/anti-viral compounds and methods of use |
| US8728465B2 (en) * | 2008-06-17 | 2014-05-20 | Cedars-Sinai Medical Center | Use of toll-like receptor ligands as adjuvants to vaccination therapy for brain tumors |
| US20110171259A1 (en) * | 2008-09-05 | 2011-07-14 | Martin Gagne | Novel Compositions and Adjuvants |
| SG173617A1 (en) | 2009-02-11 | 2011-09-29 | Univ California | Toll-like receptor modulators and treatment of diseases |
| PT2411521E (pt) | 2009-03-25 | 2015-04-21 | Univ Texas | Composições para estimulação de resistência imunitária inata de mamíferos contra patogénicos |
| WO2010115229A1 (en) | 2009-04-09 | 2010-10-14 | The University Of Melbourne | Immunogenic composition and uses thereof |
| EP2338521A1 (en) | 2009-12-28 | 2011-06-29 | Helmholtz-Zentrum für Infektionsforschung GmbH | Lipopeptide- and lipoprotein-conjugates and its use |
| EP2549990A1 (en) | 2010-03-23 | 2013-01-30 | Irm Llc | Compounds (cystein based lipopeptides) and compositions as tlr2 agonists used for treating infections, inflammations, respiratory diseases etc. |
| WO2012037612A1 (en) * | 2010-09-22 | 2012-03-29 | The University Of Melbourne | Novel immunostimulatory method |
| WO2016037240A1 (en) | 2014-09-12 | 2016-03-17 | The University Of Melbourne | Immunological reagent |
-
2011
- 2011-09-22 WO PCT/AU2011/001225 patent/WO2012037612A1/en active Application Filing
- 2011-09-22 CA CA2811957A patent/CA2811957C/en active Active
- 2011-09-22 DK DK11826223.7T patent/DK2618842T3/da active
- 2011-09-22 EP EP11826223.7A patent/EP2618842B1/en active Active
- 2011-09-22 AU AU2011305061A patent/AU2011305061B2/en active Active
- 2011-09-22 CN CN201510939940.1A patent/CN105477640B/zh active Active
- 2011-09-22 EP EP19163679.4A patent/EP3520814A1/en not_active Withdrawn
- 2011-09-22 CN CN201180051461.6A patent/CN103189072B/zh active Active
- 2011-09-22 US US13/825,679 patent/US9676819B2/en active Active
- 2011-09-22 ES ES11826223T patent/ES2735274T3/es active Active
- 2011-09-22 JP JP2013529510A patent/JP2013537892A/ja not_active Withdrawn
- 2011-09-22 EP EP20155567.9A patent/EP3669892B1/en active Active
- 2011-09-22 PL PL11826223T patent/PL2618842T3/pl unknown
-
2016
- 2016-11-04 JP JP2016216593A patent/JP6657507B2/ja active Active
-
2017
- 2017-05-16 US US15/596,427 patent/US10406100B2/en active Active
-
2019
- 2019-06-05 JP JP2019105433A patent/JP2019167369A/ja active Pending
- 2019-07-26 US US16/522,779 patent/US11351114B2/en active Active
-
2021
- 2021-06-03 JP JP2021093836A patent/JP2021130713A/ja not_active Withdrawn
-
2022
- 2022-05-24 US US17/664,717 patent/US11786458B2/en active Active
-
2023
- 2023-06-09 JP JP2023095418A patent/JP2023113902A/ja active Pending
- 2023-10-10 US US18/483,662 patent/US20240050364A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| PL2618842T3 (pl) | 2019-10-31 |
| CN105477640B (zh) | 2019-09-17 |
| US9676819B2 (en) | 2017-06-13 |
| EP2618842B1 (en) | 2019-04-24 |
| US20130230544A1 (en) | 2013-09-05 |
| US20190380952A1 (en) | 2019-12-19 |
| CA2811957A1 (en) | 2012-03-29 |
| US20220296505A1 (en) | 2022-09-22 |
| WO2012037612A1 (en) | 2012-03-29 |
| US10406100B2 (en) | 2019-09-10 |
| US11351114B2 (en) | 2022-06-07 |
| US20240050364A1 (en) | 2024-02-15 |
| JP2019167369A (ja) | 2019-10-03 |
| JP6657507B2 (ja) | 2020-03-04 |
| JP2017061504A (ja) | 2017-03-30 |
| EP2618842A4 (en) | 2014-03-26 |
| JP2013537892A (ja) | 2013-10-07 |
| AU2011305061B2 (en) | 2016-04-14 |
| CN103189072A (zh) | 2013-07-03 |
| CN105477640A (zh) | 2016-04-13 |
| ES2735274T3 (es) | 2019-12-17 |
| JP2023113902A (ja) | 2023-08-16 |
| EP3669892B1 (en) | 2024-05-08 |
| CA2811957C (en) | 2019-04-16 |
| EP2618842A1 (en) | 2013-07-31 |
| CN103189072B (zh) | 2018-02-09 |
| AU2011305061A1 (en) | 2013-05-02 |
| EP3520814A1 (en) | 2019-08-07 |
| US11786458B2 (en) | 2023-10-17 |
| US20170246312A1 (en) | 2017-08-31 |
| EP3669892A1 (en) | 2020-06-24 |
| JP2021130713A (ja) | 2021-09-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3053932T3 (da) | Hidtil ukendte ctla4-ig-immunoadhesiner | |
| BR112012028556A2 (pt) | Indóis | |
| DE102011100241A8 (de) | Nitridhalbleiterbauteil | |
| DK3225404T3 (da) | Fluidpatron | |
| CR20130111A (es) | Triazina-oxidiazoles | |
| DE10170954T8 (de) | Mikrowellendruckgarer | |
| DE112011104226A5 (de) | Käfigmutter | |
| DE102011117046A8 (de) | Doppelkupplungswindungsgetriebe | |
| DE112011101226A5 (de) | Linearwegmesssystem | |
| DK2618842T3 (da) | Hidtil ukendt immunstimulerende fremgangsmåde | |
| DE112011102080A5 (de) | Kupplungszentralausrücker | |
| DK2442899T3 (da) | Rotorskive | |
| DK2539163T3 (da) | Dækventil | |
| DE102011002623A8 (de) | Ventilsteuerzeitversteller | |
| DE112011102711A5 (de) | Hydrostataktor | |
| DK2448659T3 (da) | Rotorskive | |
| DK2447426T3 (da) | Vaske-WC | |
| DE102010019119B8 (de) | Cuttermesser | |
| DE112010005518A5 (de) | Dichtungsmanchette | |
| DE102010038420A8 (de) | Reinigungungsvorrichtung | |
| DK2596072T3 (da) | Bor-forbindelses-suspension | |
| DK2521486T3 (da) | Palpometer | |
| CO6801789A2 (es) | N-hetarilmetil pirazolilcarboxamidas | |
| DE112011101796A5 (de) | Redoxakkumulatoranlage | |
| DE102010035554B8 (de) | Fußtüröffner |